Home › Diffuse Large B-Cell Lymphoma › Nebraska › Omaha

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Omaha, NE

9 pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Omaha (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Nagre-recruitPhase 2

Nebraska Medicine-Village Pointe, Omaha
University of Nebraska Medical Center, Omaha
Nebraska Medicine-Bellevue, Bellevue · 9 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06649812

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Nagre-recruitPhase 2/3

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05139017

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

University Of Nebraska Medical Center ( Site 0110), Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Nagre-recruitPhase 1

The University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Nagre-recruitPhase 2

Nebraska Cancer Specialists, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

University of Nebraska Medical Center (UNMC), Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Nagre-recruitPhase 1/2

Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Nagre-recruitPhase 2

Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2023 · NCT04920617

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Omaha

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.